Evelo Biosciences Inc (EVLO)
May 9, 2018
See more details
Origin Bancorp (OBNK)
May 9, 2018
See more details
AXA Equitable (EQH)
May 10, 2018
See more details
Abpro Corp (ABP)
May 11, 2018
See more details
HUYA Inc (HUYA)
May 11, 2018
See more details
Pluralsight (PS)
May 17, 2018
See more details
Evo Payments Inc (EVOP)
May 23, 2018
See more details
Kiniksa Pharmaceuticals (KNSA)
May 24, 2018
See more details
Scholar Rock Holdings (SRRK US)
May 24, 2018
See more details
GreenSky Inc (GSKY)
May 24, 2018
See more details
Iterum Therapeutics (ITRM US)
May 25, 2018
See more details
M17 Entertainment Ltd (YQ US)
June 7, 2018
See more details
MeiraGTx Holdings (MGTX US)
June 8, 2018
See more details
US Xpress Enterprises Inc (USX US)
June 14, 2018
See more details
Charah Solutions Inc (CHRA US)
June 14, 2018
See more details
WITHDRAWN Adaptive Insights Inc (ADIN US)
June 14, 2018
See more details
Avalara Inc (AVLR US)
June 15, 2018
See more details
Puxin Ltd (NEW US)
June 15, 2018
See more details
Verrica Pharmaceuticals (VRCA US)
June 15, 2018
See more details
Eidos Therapeutics (EIDX US)
June 20, 2018
See more details
Avrobio Inc (AVRO US)
June 21, 2018
See more details
Kezar Life Science Inc (KZR US)
June 21, 2018
See more details
Aptinyx Inc (APTX US)
June 21, 2018
See more details
Essential Properties Realty Trust (EPRT US)
June 21, 2018
See more details
ElectroCore LLC (ECOR US)
June 21, 2018
See more details
I3 Verticals Inc (IIIV US)
June 21, 2018
See more details
Magenta Therapeutics (MGTA US)
June 21, 2018
See more details
Xeris Pharmaceuticals (XERS US)
June 21, 2018
See more details
Autolus Therapeutics Ltd (AUTL US)
June 22, 2018
See more details
Neon Therapeutics (NTGN US)
June 27, 2018
See more details
Uxin Ltd (UXIN US)
June 27, 2018
See more details
EverQuote (EVER US)
June 28, 2018
See more details
Translate Bio (TBIO US)
June 28, 2018
See more details
Goodbulk (GBLK US)
June 28, 2018
See more details
Tricida (TCDA US)
June 28, 2018
See more details
BrightView (BV US)
June 28, 2018
See more details
Forty Seven (FTSV US)
June 28, 2018
See more details
Neuronetics (STIM US)
June 28, 2018
See more details
BJ's Wholesale Club (BJ US)
June 28, 2018
See more details
Domo Inc (DOMO US)
June 29, 2018
See more details
Demo with Pete, Chaikin System
July 2, 2018 9:30 am - 10:30 am
See more details
Rubius Therapeutics (RUBY US)
July 18, 2018
See more details
Coastal Financial Corp (CCB US)
July 18, 2018
See more details
Crinetics Pharmaceuticals (CRNX US)
July 18, 2018
See more details
Establishment Labs Holdings (ESTA US)
July 19, 2018
See more details
Tilray (TLRY US)
July 19, 2018
See more details
AFG Holdings (AFGL US) POSTPONED
July 19, 2018
See more details
Allakos (ALLK US)
July 19, 2018
See more details
Constellation Pharmaceuticals (CNST US)
July 19, 2018
See more details
First Western Financial (MYFW US)
July 19, 2018
See more details
Replimune Group (REPL US)
July 20, 2018
See more details
Provention Bio (PRVB US), Priced on 07/19/2018
July 24, 2018
See more details
Aquestive Therapeutics (AQST US)
July 25, 2018
See more details
Bloom Energy (BE US)
July 25, 2018
See more details
Berry Petroleum (BRRP US) from OTC to NASDAQ
July 26, 2018
See more details
Tenable Holdings (TENB US)
July 26, 2018
See more details
Linquidia Technologies (LQDA US)
July 26, 2018
See more details
Endava PLC (DAVA US)
July 26, 2018
See more details
Aurora Mobile (JG US)
July 26, 2018
See more details
Focus Financial Partners (FOCS US)
July 26, 2018
See more details
Cango Inc (CANG US)
July 26, 2018
See more details
Pinduoduo (PDD US)
July 26, 2018
See more details
Opera Ltd (OPRA US)
July 27, 2018
See more details
Sonos Inc (SONO US)
August 2, 2018
See more details
Cushman & Wakefield PLC (CWK US)
August 2, 2018
See more details
Arlo Technologies (ARLO US)
August 3, 2018
See more details
Meeting with Kent
August 8, 2018 9:00 am - 10:00 am
See more details
Mesa Air Group (MESA US)
August 9, 2018
See more details
Amalgamated Bank (ANYB US)
August 9, 2018
See more details
Vaccinex Inc (VCNX US)
August 9, 2018
See more details
111 Inc (YI US)
September 12, 2018
See more details
Principia Biopharma Inc (PRNB US)
September 14, 2018
See more details
Navios Maritime Containers (NMCI US)
September 14, 2018
See more details
Qutoutiao (QTT US)
September 14, 2018
See more details
X Financial (XYF US)
September 19, 2018
See more details
Bank7 Corp (BSVN US)
September 20, 2018
See more details
Remora Royalties (RRI US)
September 21, 2018
See more details
Viomi Technology (VIOT US)
September 25, 2018
See more details
Entasis Therapeutics (ETTX US)
September 26, 2018
See more details
Capital Bancorp (CBNK US)
September 26, 2018
See more details
SurveyMonkey Inc (SVMK US)
September 26, 2018
See more details
CooTek Cayman Inc (CTK US)
September 26, 2018
See more details
Ra Medical Systems (RMED US)
September 27, 2018
See more details
Kodiak Sciences (KOD US)
October 4, 2018
See more details
Osmotica Pharmaceuticals (OSMT US)* Postponed
October 11, 2018
See more details
Equillium (EQ US)
October 12, 2018
See more details
Riley Exploration-Permian (REPX US) - NYSEAmerican* Postponed
October 17, 2018
See more details
SI-BONE (SIBN US)* (upsized)
October 17, 2018
See more details
Osmotica Pharmaceutical (OSMT US)*
October 18, 2018
See more details
Studio City International (MSC US)
October 18, 2018
See more details
Niu Technology (NIU US)
October 19, 2018
See more details
LogicBio Therapeutics (LOGC US)
October 19, 2018
See more details
Alzheon (ALZH US)* (most likely canceled again)
October 24, 2018
See more details
Gamida Cell Ltd (GMDA US)
October 26, 2018
See more details
Axonics Mudolation Technologies (AXNX US)
November 1, 2018
See more details
CNFinance (CNF US)
November 6, 2018
See more details
Vapotherm (VAPO US)
November 14, 2018
See more details
Weidai (WEI US)
November 15, 2018
See more details
Centrexion Therapeutics (CNTX US)
November 15, 2018
See more details
Autonomous Control Systems Laboratory
December 21, 2018
Tokyo Stock Exchange
See more details
New Fortress Energy (TRADING)
January 31, 2019
NASDAQ Global Select
See more details
BankFlorida (POSTPONED)
February 11, 2019
Postponed
BFL US
$9.50 - $10.50/share
Offer Size: 4.2 million ~81.80% float
BankFlorida, formerly FirstCity Bank of Commerce, is a Florida state-charted community bank based in Palm Beach Gardens, Florida. The bank provides general commercial and personal banking services, especially to SMEs.
See more details
Chunbo (TRADING)
February 11, 2019
KOSDAQ
40,000 won/share, high-end of its expected price range of ₩35,000 - ₩40,000/share
Shares: 2.5 million
Established in 2007, Chunbo is a fine chemical material provider in Korea. The company manufactures and supplies specialized chemical to industries including LCD, semiconductor, pharmaceutical etc.
See more details
Sequana Medical (TRADING)
February 11, 2019
Brussels Stock Exchange
€8.5/share, lower end of its indicative price range €8.50 - €9.00/share
Shares: 3,235,294 shares, ~24.7% float
Sequana Medical is a commercial stage medical device company headquartered in Ghent, Belgium established in 2005. Sequana develops medical devices for liver disease, heard failure, malignant ascites and other fluid imbalance disorders. The company has one commercialized product, the alfapump, which pumps out the ascites and help the body to eliminates ascites naturally. The product has not yet received regulatory approval in the U.S. but has received approval in EU. Existing shareholders have irrevocably committed to subscribe €20.5 million in the offering, i.e. 74.55% of the offering.
https://www.sequanamedical.com/
See more details
Anchiano Therapeutics (TRADING)
February 12, 2019
Nasdaq Capital Market
Fixed price at $14.55/ADS (based on the last reported sale price on TASE on 1/28/2019)
Shares: 2.4 million ADSs (representing 12 million ordinary shares), ~36.5% float
Anchiano is an Israeli clinical-stage gene therapy company focused on treatment for early-stage bladder cancer. The lead product candidate has showed potential to delay and (in some cases) eliminate early bladder cancer progression in Phase 1/2 clinical trials. The company commenced operation in 2004 and had a trading history on TASE under the name BioCancell (BICL IT) since 2012. Exiting shareholders have indicated an interest in purchasing up to $17.5 million of the ADSs at offer (~50% of initial offering size).
https://www.anchiano.com/
See more details
Virgin Trains USA (WITHDRAWN)
February 13, 2019
Nasdaq
Withdrawn
VTUS US
$17.00 - $19.00/share
Shares: 28,334,000 shares, ~17.1% float
Virgin Trains USA Inc is a private equity funds backed railroad operator and commenced service in 2018. The company was formed in 2013 under AAF Holdings and partnered up with Virgin Enterprises Limited (VEL) in November 16 2018 to re-brand its originally Brightline to Virgin Trains USA. The company owns and operates an express passenger intercity rail system between Miami and West Palm Beach, Florida. Virgin Trains acquired XpressWest in September 2018 to expand operation to California and Las Vegas and is expected to close the $120 million acquisition in Q1 2019. Fortress Fund will hold ~81.6% of the common stock. Corvina Holdings (affiliate of Virgin Enterprises Limited) has agreed to purchase up to 2% of the number of shares outstanding. The company has a valuation of $3.15 billion on high-end yet only has a $5.2 million sales for the first nine months of operation in 2018.
See more details
ESCON Japan REIT Investment (TRADING)
February 13, 2019
Tokyo Stock Exchange
Priced at 101,000 yen/share
Offer Size: 19.03 billion yen (approximately $172.80 million)
Established in 2016, ESCON Japan REIT Investment Corporation (EJR) is the subsidiary of ES-CON Asset Management, the real estate investment advisory arm of the 1995 Osaka-based real estate veteran ES CON Japan. The REIT portfolio includes local area shopping center and leasehold land in Osaka and Okayama.
https://www.esconam.jp/en/
See more details
Avedro (TRADING)
February 14, 2019
Nasdaq Global Market
$14.00 - $16.00/share
Shares: 5 million shares ~29.3% float
Avedro is a commercial-stage ophthalmic medical device company. First incorporated under the name ThermalVision in 2002, the Waltham, MA-based company has an FDA approved treatment of progressive keratoconus and corneal ectasia following refractive surgery launched in 2016 and product for vision correction procedures in EU. The small-cap company had raised $218.5 million in previous private funding and has a ~9.9 P/S ratio.
http://avedro.com/location/
See more details
TCR2 Therapeutics (TRADING)
February 14, 2019
Nasdaq Global Market
$14.00 - $16.00/share
Shares: 5 million shares, ~21.56% float
TCR2 Therapeutics is a PE-backed early clinical-stage immunotherapy company commenced operation in 2015. The Cambridge MA-based company specializes in T cell therapies for cancer. The IND of its lead product candidate was just cleared by FDA. There are total of 5 product candidates in TCR2's pipeline target either solid tumors or hematological malignancies, with the most advanced program in preparation of Phase 1/2 clinical trial and the rest either in IND application process or still in discovery stage. The company has license agreement with Harpoon Therapeutics (HARP US), which was listed on Nasdaq a week ago. Certain existing stockholders have indicated an interest in purchasing approximately $30 million of shares in this offering, i.e. ~37.5% of this offering.
See more details
Cibus Global (POSTPONED)
February 14, 2019
Nasdaq
Postponed
CBUS US
$14.00 - $16.00/share
Shares: 6,666,667 shares ~28.6% float
Cibus Global is a biotech x agricultural company founded in 2001. Based in San Diego, CA, the company use non-transgenic gene-editing technology, the Rapid Trait Developement System (RTDS), to edit plant (crops) genes. The company generates revenue from the sales of sulfonylurea-tolerant canola seeds (SU Canola) in North America, collaboration and research, and license plant traits to leading seed companies. Cibus established partnerships with food processing companies Cargill and Bunge to promote their canola seed sales. Fidelity Investments will be holding ~6% of the shares after the offering.
https://www.cibus.com/
See more details
Stealth BioTherapeutics (TRADING)
February 15, 2019
Nasdaq Global Market
$12.00 - $14.00/share
Shares: 6.2 million ADSs, representing 74.4 million shares, ~18.78% float
Stealth BioTherapeutics is a clinical-stage biotech company began operation in 2006 with executive office located in Newton, MA. The company focuses on mitochondrial medicine. Stealth has 2 clinical-stage product candidates in its development pipeline with the lead indicator for Primary Mitochondrial Myopathy in Phase 3 clinical trial, and for Barth Syndrom in discussion of NDA submission. Existing principle shareholder has indicated an interest in purchasing up to $60 million of ADS in this offering, i.e. ~75% of the offering.
www.stealthbt.com
See more details
BMIT Technologies (TRADING)
February 18, 2019
Valletta
€0.49/share
Offer Shares: 99,761,701 shares (79,261,701 shares have been allocated amongst financial intermediaries)
Registered in 2009 as GO Data Centre Services in Malta, BMIT Technologies provides data center services in Malta. The company owns and operates private international managed network, provides cloud services and other IT solutions. Go p.l.c. will hold a minimum of 51% of the issued share of BMIT following the offering. P/S ratio is ~4.66x based on projected revenue.
See more details
Zen Corp Group (TRADING)
February 20, 2019
Bangkok
Thai Baht 13.00/share
Shares: 75.00 million shares
See more details
Cellid (TRADING)
February 20, 2019
KOSDAQ
33,000 won/share, above 25,000 - 31,000/share range
Shares 1.20 million shares
See more details
Gear 1 Spa (TRADING)
February 26, 2019
Borsa Italiana
€10/share
Offer: 3 million shares
See more details
CStone Pharmaceuticals (TRADING)
February 26, 2019
Hong Kong Stock Exchange
2616 HK
Priced at HK$12.00/share, little above midpoint of its HK$11.10 - 12.80/share expected range
Shares: 186,396,000 shares ~18.94% float
CStone Pharmaceuticals is a Chinese clinical-staged biopharmaceutical company focused on immuno-oncology. The company is currently working on 14 product candidates in its pipeline from pre-clinical stage to late-stage with partners like Agios and Blueprint. The most advanced drug candidate treating relapsed or refractory AML with Agios. CStone was founded by WuXi Healthcare Ventures, incorproated in 2015 and started research and development operation in 2016. CStone is said to priced at the upper-half of the range and raised HK$2.24 billion. The VC fund will continue to be the largest shareholders after the Listing with ~29.76% shares. Cornerstone investors, including existing shareholders have agreed to subscribe approximately 1/3 of the offer shares.
See more details
Super League Gaming (TRADING)
February 26, 2019
NASDAQ CM
$10.00 - $12.00/share
Shares: 2,272,727 shares, ~27.26% float
Super League Gaming operates a gaming platform that connects amateur esports gamers, venues, game publishers and brand partners. Founded in 2014 as Nth Games, Inc, the CA-based company established league teams in Minecraft, League of Legends, Clash Royale and Fortnite. Super League Gaming generates revenues from advertising and sponsorship as well as subscriptions and event holding. Sales has grown 420% from 2017 to 2018 yet the company only generates ~1 million in sales.
The final offer price was set at $11/share
See more details
Dexin China (TRADING)
February 26, 2019
Hong Kong Stock Exchange
2019 HK
HK$2.32 - 3.25/share
Shares: 532,000,000 shares, ~20.21% float
Dexin is a comprehensive property developer in Zhejiang Province, China. The company focuses primarily on the development and sales of residential properties and the development, operation and management of commercial and mixed-use properties. Dexin was founded in 1995. Revenue of Dexin can be breakdown by property (residential, car parks, & commercial spaces) development and sales (99.3%), property construction services and project management services (0.2%), property leasing (0.3%) and hotel operations (0.2%). Several cornerstone investors has entered the agreement to subscribe the IPO.
The final offer price was set at HK$2.80/share.
See more details
Kaleido Biosciences (TRADING)
February 28, 2019
$20.00 - $22.00/share ***Priced at $15.00/share***
Shares: 4,761,905 shares ~16.2% float ***Upsize to offer 5 million shares***
Kaleido Biosciences is a Massachusetts-based, early clinical-stage microbiome metabolic therapies (MMT) company founded in 2015. The company has conducted several non-IND human clinical studies with its most advanced product candidates in the pipeline under potential IND Filing stage and intend to initiate a Phase 2 clinical trial in first half of 2019. Lead product candidates target treatment of hyperammonemia in urea cycle disorders and hepatic encephalopathy. The company was created in Flagship Labs by VC firm Flagship Pioneering, one of the largest VCs specializing in the biotech and healthcare space.
See more details
JDC (TRADING)
March 5, 2019
490.00 - 510.00 yen/share
Offer Size: 13.46 million shares ~13.7% float
Founded in 1951, JDC is a Japanese construction and civil engineering company.
The final offer price was set at 510 yen/share.
See more details
Ecopro BM (TRADING)
March 5, 2019
KOSDAQ
37,500 - 42,900 won/share ***Priced at ₩48,000/share***
Offer Shares: 3.6 million shares ~18.1% float (Upsized from 3.00 million shares offering)
Ecopro BM is a 2016 spin-off from the parent company ECOPRO. Ecopro BM is a material/battery company that specializes in developing and the mass-producing of nickel cathode materials in Korea.
See more details
Yincheng International (TRADING)
March 6, 2019
Hong Kong Stock Exchange
HK$2.00 - HK$2.48/share ***Priced at HK$2.38/share***
Shares: 354,260,000 shares ~25% float
Yincheng International is a Chinese property developer in Nanjing and the surrounding Yangtze River Delta Megalopolis. The company has been engaged in property development with a track record in Nanjing since 2002. Sale of residential and commercial properties (~98.7%) and rental income from investment properties owned by the group (1.3%) are the only sources of revenue. Yincheng International outsource construction works of all its property development projects.
See more details
Shockwave Medical (TRADING)
March 7, 2019
NASDAQ GM
US$14.00 - US$16.00/share ***Priced at $17/share***
Offer Shares: 5,000,000 shares ~19.52% float ***Upsized to 5,700,000 shares***
Shockwave is a medical device company for the treatment of atherosclerosis. Incorporated in 2009, the company has two commercialized products, M5 catheter in both United States and Europe since 2018 for treating peripheral artery disease, and C2 catheter in Europe for treating coronary artery disease. The company holds its R&D facility in Santa Clara, CA and a manufacture sit in Fremont. The company is trading at P/E x30+ times. Certain existing shareholders have options to purchase up to $10.5 million of the offering (~13%)
See more details
Lightspeed POS (TRADING)
March 8, 2019
Toronto Stock Exchange
CA$13.00 - CA$15.00/share ***Priced at CA$16.00/share***
Offer Shares: 15,000,000 shares, ~22.86% float
Headquartered in Montreal, Canada, Lightspeed POS is a software company established in 2012. Lightspeed provides an e-commerce platform for small and medium sized businesses with a focus on retailer and restaurateur. The company also provides point to sale (POS) system and payment solutions for small businesses to manage daily operations.
See more details
Futu (TRADING)
March 8, 2019
NASDAQ GM
US$10.00 - 12.00/share ***Priced at $12.00/share***
Offer Shares: 7,500,000 ADSs (Each ADS represents eight Class A ordinary shares) ~17.24% float of Class A shares; or ~6.72% float of all class shares ***Downsized from 10.9 million ADSs***
Futu is a online-based brokerage services company in Hong Kong and China. Founded in 2007 as a internet technology and software development services, the company launched the online brokerage business in 2012 and has a significant market share in the online retail securities markets in both Hong Kong and China since 2015. Futu provides a technology-empowered brokerage platform. Futu generates the majority revenue from brokerage commission and handling charge (~50.3%) and interest income (~44.4%). The company has post positive earnings in 2018. Backed by Tencent, Matrix & Sequoia Capital, Futu is valued at close to $1.3 billion. While the valuation of the firm was at $2.5 billion end of 2018. Futu has entered a concurrent private placement with General Atlantic Singapore to purchase US$70 million in Class A shares at offer price (if within range).
See more details
Zhejiang New Century Hotel Management (TRADING)
March 11, 2019
Hong Kong Stock Exchange
1158 HK
HK$13.37 - HK$20.05/share ***Priced at HK$16.50/share***
Offer Size: 70,000,000 H shares
Zhejiang New Century Hotel Management is a hotel group in China. The company operates and manages mid-scale to upscale resort hotels, full service hotels and select service hotels. The hotel group was established in 1988 in Hangzhou, Zhejiang. The group generate revenue through hotel operation (~90%) and hotel management (~10%). New Century has leased ~22.3% of hotel rooms in operation and owns ~1.2% of the hotel room in operation. The group has ~65.6% of hotel rooms in operation under full service management agreement and ~10.9% of the hotel rooms in operation pursuant to the franchise agreement. Ctrip Hong Kong (CTRP US) and GreenTree Hospitality Group (GHG US) has agreed to purchase a total of US$62 million of the offering (~50%).
See more details
DWF Group (TRADING)
March 11, 2019
London Stock Exchange
GBp 122.00/share
Offer Shares: 78.05 million
See more details
Sankei Real Estate (TRADING)
March 12, 2019
Tokyo Stock Exchange
JP 98,000 - 100,000 yen/share ***Priced at 100,000 yen/share***
Shares Offered: 227,200 shares
Established in 2018, Sankei Real Estate Inc is under management by Sankei Building Asset Management Co., Ltd., a wholly owned subsidiary of The Sankei Building Co., Ltd. Sankei Building is a Japanese real estate company active in real-estate construction, leasing, brokerage, management and other associated businesses since 1951.
See more details
WingArc1st (WITHDRAWN)
March 13, 2019
Tokyo Stock Exchange
JP 1,690 - 1,970 yen/share
Founded in 1993 and headquartered in Tokyo, WingArc1st is a Japan-based software company that provides data solution for companies. WingArc offers enterprise management software platforms.
WingArc1st is set to raise up to 41.28 billion yen (US$379.35 m)
See more details
Dreamtech (TRADING)
March 14, 2019
Korea Exchange
Price Range: KRW11,000 - KRW13,000/share ***Priced ₩13,000/share***
Founded in 1998 as a Samsunng Electronics partner company in Korea, Dreamtech develops and produces automotive LED and home appliance LCD display modules as well as sensor, touch, finger scan modules for mobile phones.
See more details
Binjiang Service Group (TRADING)
March 15, 2019
Hong Kong Stock Exchange
HK$5.40 - 7.00/share ***Priced at HK6.96/share***
Offer Shares: 66.70 million
Established in 1995, Binjiang Service Group is a property management service provider in China (with a substantial market share in high-end residential properties in Hangzhou). The revenue of Binjiang can be divided into three main segments including property management services (64.9%), value-added services to non-property owners (27.5%), and value-added services to property owners (7.6%). Three cornerstone investors have agreed to subscribe a total of over 40% of the total offer shares.
See more details
China Risun Group (TRADING)
March 15, 2019
Hong Kong Stock Exchange
HK$2.76 - HK$3.18/share ***Priced at HK$2.80/share***
Offer Shares: 600 million shares ~22.1% float
China Risun Group is an integrated coke, coking chemical and refined chemical producer and supplier in China. The group was established in 1995 with all production bases in Hebei province. The revenue breakdown to coke and coking chemical (45.5%), refined chemicals (41.0%) and trading (13.5%). The major customers are iron and steel industry participators and chemical products manufacturers. The five largest customers accounts for ~18.1% of Risun's total revenue. 8 cornerstone investors have agreed to purchase ~40% of the offering
See more details
International Alliance Financial Leasing (TRADING)
March 15, 2019
Hong Kong Stock Exchange
HK$0.84 - 1.67/share ***Priced at HK$0.85/share***
Offer Shares: 495.00 million ~33% float
Established in 2014 as Nanshan Leasing, a wholly-owned subsidiary of Nanshan Group, International Alliance Financial Leasing (AI Leasing) is a finance leasing and advisory services provider in China. Headquartered in Beijing, AI Leasing targeted customers in the healthcare, aviation and public infrastructure industries. It is one of the largest independent non-state owned aircraft finance leasing company in China. AI Leasing profit from both sale-leaseback (~86% of revenue) and direct finance leasing (~14%). Union Capital will control approximately 51.23% of the company upon completion of the offering.
See more details
Aoyuan Healthy Life Group (TRADING)
March 18, 2019
Hong Kong Stock Exchange
HK$3.48 - 4.30/share
Offer Shares: 175.00 million ~25% float
Aoyuan Healthy Life is a property management service and commercial operational service provider in China since 2011. This listing will constitute a spin-off from China Aoyuan.
The Group provides conventional property management services for both residential and non-residential properties from sales assistance to community value-added services. Aoyuan also provides commercial operational services from business tenant sourcing services to management services for shopping malls. The company generates approximately 2/3 of revenue from conventional property management (72.8%). While Aoyuan work with third-party property developers, 94.7 % of its revenue were from managing properties developed by its parent company. Immediately following the completion of this offering, China Aoyuan will still hold ~56.6% of the total issued shares, while Dawn Agile, the pre-IPO investor of Aoyuan Healthy Life, will hold ~18.4%. Cornerstone investor has agreed to subscribe >5% of this offer.
See more details
Copro-Holdings
March 19, 2019
Tokyo Stock Exchange
JPY 2050.00 - 2090.00/share
Offer Shares: 1.40 million, ~28% float
Established in 2006 as Copro-Engineered, Copro is a recruitment company that operates in the temporary staffing business with a focus on construction engineers in Japan.
See more details
Minkabu The Infonoid
March 19, 2019
Tokyo Stock Exchange
JPY 950.00 - 1,050.00/share ***Priced at 1,050 yen/share***
Offer Size: 2,740,200 shares, ~21.86% float
Founded in 2006 and commenced operation in 2007, Minkabu the Infonoid is a Tokyo, Japan-based fiinancial news media company. Minkabu provides financial information using crowd analysis and automatic analysis. The company supports multiple media companies to provide stock information and fx information. Minkabu also offers system development service.
See more details
Up Fintech
March 20, 2019
NASDAQ GS
Price Range: $5.00 - $7.00/ADS
Shares Offered: 13,000,000 ADS (representing 195,000,000 Class A shares) ~11.8% float of Class A shares; or ~9.8% float (of total ordinary shares Class A & B)
Up Fintech (Tiger Brokers) is a Chinese online brokerage platform developer and operator. Headquartered in Beijing, the company was founded in 2014. The trading platform was launched in August 2015. Tiger is claimed to be the largest online broker for Chinese investors in terms of U.S. securities trading with a market share of approximately 58.4%. Yet, it has not been profitable since inception. The company provides brokerage services, corporate services and asset management. Tiger generates majority revenue from commission fees (77.6%) generated from brokerage services and financing service fees and interest income (19.4%) from margin loans and short selling services. Interactive Brokers (through IB Global Investment LLC) and Xiaomi (through People Better Limited) will hold ~7.6% and 12.6% of the company respectively. The company relies on Interactive Brokers to execute, settle and clear trades and to perform margin financing services. It is an "introducing broker" to Interactive Brokers but with a valuation close to $1.0 billion.
See more details
Diaceutics
March 21, 2019
London Stock Exchange
Priced 76.00 pence/share
Shares Offered: 22,368,427
Founded in 2005, Diaceutics is a commercialized diagnostic data analytics and implementation services provider. The company provides services to pharmaceutical companies to support precision medicine therapies.
See more details
Levi Strauss & Co
March 21, 2019
NYSE
Price Range: $14.00 - $16.00/share
Shares Offered: 36,666,667 shares Class A common stock (9,466,557 shares NEW shares & 27,200,110 shares offered by selling stockholders) ~9.5% float (of total Class A and B common stock outstanding)
Founded in San Francisco, CA in 1853, Levi Strauss is a jean apparel company that invented blue jeans. Levi's was once traded on NYSE in 1971 but returned to being a privately-held company in 1985. The iconic-jeans company also established global market share position in non-jeans bottoms and tops as well as footwear and accessories in U.S., Europe (29% of net revenues) and Asia (16% of net revenues). Wholesale channel, franchise stores sales, and DTC channel (company-operated mainline and outlet stores, shop-in-shop, eCommerce sites) accounts for 57%, 7% and 35% of net revenues in 2018 respectively.
Levi's is valued at close to $6.2 billion if priced on high-end. The denim company has a P/S ratio of 1.1x and a dividend yield of ~1.78% at current valuation. The Haas family will still hold ~82.1% of total voting power following the offering.
See more details
Alight
March 22, 2019
NASDAQ GS
Price Range: $22.00 - $25.00/share
Shares Offered: 32,000,000 shares, ~24% float (or 16% if Pre-IPO Unitholders exchange all LLC Units)
Alight (previously Aon's benefits admin and HR BPO platform) is a Human Capital Management (HCM) company focus on providing solutions for clients to manage health, wealth and HR needs. Headquartered in Lincolnshire, IL, Alight has 25+ years experiences in the HR space in hosted business and cloud-based solutions. Hosted service is scheduled to expire by 2023 and the company will solely focus on cloud-based HR solutions. Alight has entered into strategic partnerships with Alegeus and Personal Capital for its health and wealth business segment, and Workday for its cloud HCM platform services. Blackstone acquired Alight from Aon in 2017 for $4.3 billion. Blackstone will hold ~30% of the outstanding Class A common stock and ~40% of voting power. Other significant shareholders includes Abu Dhabi Investment Authority (ADIA) and GIC. Valued at ~$5.1 billion, the company has a P/S ratio of ~2.15x if priced at $25.00/share.
See more details
Shanghai Dongzheng Automotive Finance
March 26, 2019
Hong Kong Stock Exchange
Price Range: HK$4.20 - HK$6.30/share
Shares Offered: 533,336,000 shares ~25.00% float
Established in 2015, Shanghai Dongzheng Automotive Finance is a spin-off of ZhengTong, a Chinese luxury-brand car dealer group. Shanghai Dongzheng Automotive Finance provides tailored auto finance products and services for the purchase of luxury-brand cars. Shanghai Dongzheng generates revenue from interest, fee and commission from both self-operated retail loan, retail loan facilitation and dealer loan business.
See more details
IntelliCentrics Global
March 27, 2019
Hong Kong Stock Exchange
Price Range: HK$5.32 - HK7.19/share
Shares Offered: 80,900,000 shares ~18% float
Headquartered in Dallas, Texas, IntelliCentrics Global operates a credentialing platform for compliance and security purposes in the healthcare industry. The company as formed in 2007 as USA deView acquired certain assets of RepTrax to provide solutions for healthcare providers with a paying subscription platform. The platform collects, processes and verifies data and information in accordance of locations where healthcare services are provided (LoCs). IntelliCentrics offers both vendor credentialing solution, medical credentialing solution and add-on services (include onling training etc.). 94% of revenue was generated from subscription fees for the vendor credentialing solution. IntelliCentrics operates in the United States (98.77%), Canada (0.05%) and United Kingdom (1.18%) and is entering into the Chinese market.
See more details
Genfit
March 27, 2019
NASDAQ GM
GNFT FP (12/11/2006 IPO priced at €9.00/share, listed on Euronext Paris)
Offering price will be determined by price of its ordinary shares on Euronext Paris. On March 13, 2019, the last reported sale price of our ordinary shares on Euronext Paris was €23.42 per ordinary share, equivalent to a price of $26.33 per ADS, assuming an exchange rate of €0.8894 per U.S. dollar, the exchange rate on March 8, 2019.*
Shares Offered: 5,000,000 shares
Genfit is a late-stage clinical biopharmaceutical company targeting metabolic and liver related diseases. The lead drug candidate is under Phase 3 clinical trial and Phase 2 clinical trial for potential treatment for nonalcoholic steatohepatitis and primary biliary cholangitis respectively. The company was incorporated in 1999 in France. The company generates some revenue principally from tax credits, sublease of corporate headquarteres, funds from co-research alliances from the past.
See more details
Genomictree
March 27, 2019
Korea New Exchange
The shares were first listed on Konex Exchange on 7/19/2016
Price Range: ₩17,000 - ₩25,000/share ***Priced at 27,000 won/share***
Shares Offered: 4.00 million shares
Founded in 2000, Genomictree is a molecular diagnostic company that provides diagnostic technology and product for healthcare market. The company had a commercialized DNA methylation biomarker-based non-invasive cancer molecular diagnostic product for the early detection of cancer. The detection product for colorectal cancer was approved by Korea FDA in 2014.
See more details
Koolearn Technology
March 28, 2019
Hong Kong Stock Exchange
Price Range HK$9.30 - HK$11.10/share
Shares Offered: 164,513,000 shares ~18.00% float
Koolearn Technology is a spin off of New Oriental (EDU US) with previously listing history on NEEQ (8398966) in China. The company provides online extracurricular education service in China leveraged on New Oriental's brand recognition. Koolearn provides college education (college test preparation, overseas test preparation, English learning etc.,) K-12 education, and little pre-school education for both individual students and institutional customers such as universities, public libraries and online video streaming service providers.
See more details
Hyundai Autoever
March 28, 2019
Korea Stock Exchange
Price Range: ₩40,000 - ₩44,000/share ***Priced at 48,000 won/share***
Shares Offered: 3.51 million shares
Founded in 2000 and headquartered in Seoul, Hyundai AutoEver is a Korean ICT service provider. The company is owned by Hyundai Motor Group and its affiliates including Kia Motors and Hyundai Mobis. Hyundai AutoEver specializes in software development and system integration and other IT-related services for automobile sales.
See more details
CanSino Biologics
March 28, 2019
Hong Kong Stock Exchange
Price Range: HK$21.00 - HK$22.00/share
Shares Offered: 57,248,600 shares ~28.24% float
Established in 2009, CanSino is a vaccine company in Tianjin, China. CanSino develops, manufactures vaccines. The company is developing 15 vaccine candidates with 3 near-commercial ones for meningococcal diseases and Ebola virus disease. Cornerstone investors have agreed to subscribe >25% of the total number of offer shares.
See more details
Lyft
March 29, 2019
NASDAQ GS
Price Range: US$62.00 - US$68.00/share
Shares Offered: 30,770,000 shares ~10.8% float of Class A and B outstanding
Lyft is a on-demand ridesharing company launched in 2012 with sole presence in United States and Canada. Lyft offers variety of transportation options from conventional ridesharing, bikes and scooters to public transit and autonomous vehicles services with Aptiv. Lyft is seeking a $20 billion valuation at high-end and a ~8.96x P/S ratio.
See more details
New Fortress Energy
January 31, 2020
NASDAQ
See more details
Disclaimer:
The IPOX Deal Calendar may not provide a complete list of all global initial public offerings (IPOs). Deals presented are subject to minimum market capitalization requirement and minimum deal size requirement. Companies pursing an IPO on Over-The-Counter (OTC) markets, best efforts offerings, closed-end fund (CEF), special purpose acquisition companies (SPAC), mainland China stock (A share) and Indian stocks are not included. Please refer to the Legal Disclaimer.
